Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Xeroderma pigmentosum].

S Takeuchi

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |August 2, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Xeroderma pigmentosum (XP) is a genetic disorder causing sun sensitivity and high skin cancer rates. This review covers XP

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phylogeny of regulatory regions of vertebrate tyrosinase genes.

    Pigment cell research·1992
    Same author

    [The 5th report on long-term chemotherapy using erythromycin (EM) for chronic lower airway infection--cases followed over 7 years].

    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases·1992
    Same author

    Nitric oxide synthase responsible for L-arginine-induced relaxation of rat aortic rings in vitro may be an inducible type.

    British journal of pharmacology·1992
    Same author

    Meningioma in a neonate: case report.

    Surgical neurology·1992
    Same author

    Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.

    British journal of pharmacology·1992
    Same author

    [A report of two cases of multilocular cystic renal cell carcinoma: review of 51 cases reported and the results of a prognostic survey].

    Hinyokika kiyo. Acta urologica Japonica·1992
    Same journal

    [Development of novel therapeutics for multiple myeloma and improvement of drug lag].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Clinical pharmacy services to patients of immunomodulatory drugs].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    See all related articles

    Area of Science:

    • Genetics
    • Molecular Biology
    • Dermatology

    Context:

    • Xeroderma pigmentosum (XP) is an autosomal recessive disorder.
    • XP patients exhibit extreme sun sensitivity, leading to a high incidence of skin cancer.
    • Neurological abnormalities are observed in some XP patient groups.

    Purpose:

    • To review the pathological features of Xeroderma pigmentosum (XP).
    • To discuss the genetic defects underlying different XP complementation groups.
    • To summarize current knowledge on DNA repair mechanisms in XP.

    Summary:

    • XP is classified into eight complementation groups (A-G and XP-Variant).
    • XP groups A-G involve defects in nucleotide excision repair (NER).
    • XP-Variant involves a defect in translesion DNA synthesis.

    Impact:

    • Understanding XP's genetic basis aids in diagnosis and potential therapies.
    • Elucidating NER and DNA repair pathways in XP offers insights into broader genomic stability.
    • This review consolidates current knowledge for researchers and clinicians in XP.